Trump's nominee for U.S. Attorney in Washington, D.C. faces resistance from Senate Republicans over controversial statements and stance on January 6 defendants.
Met Gala 2025 featured bold fashion statements, controversy, and tributes to tailoring and cultural heritage.
Vertex Pharmaceuticals reports mixed Q1 2025 results, with revenue rising but missing expectations, and faces intellectual property issues in Russia, but raises 2025 guidance and sees strong uptake for its new pain drug.
Trump's nominee for U.S. Attorney in Washington, D.C. faces resistance from Senate Republicans over controversial statements and stance on January 6 defendants.
Met Gala 2025 featured bold fashion statements, controversy, and tributes to tailoring and cultural heritage.
Vertex Pharmaceuticals reports mixed Q1 2025 results, with revenue rising but missing expectations, and faces intellectual property issues in Russia, but raises 2025 guidance and sees strong uptake for its new pain drug.